Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβ peptides of Alzheimer's disease
- 1 April 1998
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1406 (3) , 291-298
- https://doi.org/10.1016/s0925-4439(98)00014-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid DepositsBiochemical and Biophysical Research Communications, 1997
- The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar PreamyloidJournal of Biological Chemistry, 1996
- Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1QJournal of Neuroscience Research, 1994
- beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Peptide Compositions of the Cerebrovascular and Senile Plaque Core Amyloid Deposits of Alzheimer′s DiseaseArchives of Biochemistry and Biophysics, 1993
- Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.Journal of Biological Chemistry, 1993
- Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.Journal of Biological Chemistry, 1992
- pH-dependent structural transitions of Alzheimer amyloid peptidesBiophysical Journal, 1991
- Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic xray diffraction patternBiochemical and Biophysical Research Communications, 1987
- Amyloid plaque core protein in Alzheimer disease and Down syndrome.Proceedings of the National Academy of Sciences, 1985